The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention ...

Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. Researchers have long known that people ...

Focus ADHD is an online psychiatric clinic based in Des Moines, Iowa, offering personalized treatment for adult professionals living with ADHD. The clinic provides expert medication management, ...

Telehealth services could possibly have merits for treating children with ADHD symptoms. A study published in the Journal of the American Academy of Child & Adolescent Psychiatry found that children ...

Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...

ADHD diagnosis, which largely originated in the United States, began to spread to the rest of the globe in the late 1990s, ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

Australia is loosening regulations so that general practitioners (GPs) can meet the growing demand for attention-deficit/hyperactivity disorder (ADHD) care. But some ...